Dipti Patel-Donnelly, a medical oncologist at the Virginia Cancer Specialists, leads a study titled “How Can We Manage High-Risk Hematologic Malignancies in the Community?” The study investigates the impact of integrating novel agents, BiTe therapy, CAR-T, and transplantation into the standard of care for hematologic malignancies in community settings.
Dr. Patel-Donnelly shares insights based on her experience, discussing the challenges and opportunities associated with implementing advanced therapies in local cancer care. The educational session emphasizes the need to address access issues for patients with hematologic malignancies in the community, focusing on specific diagnostic, supportive, and treatment challenges in acute leukemia, high-grade lymphomas, and multiple myeloma. Dr. Patel-Donnelly offers perspectives on managing these challenges to optimize patient outcomes.
The study also highlights the role of clinical trials in increasing access, diversity, and treatment options in the community. Dr. Patel-Donnelly discusses the benefits of clinical trial participation for both patients and the local healthcare infrastructure. Additionally, she shares insights into strategies and initiatives effective in encouraging greater participation in clinical trials within the community oncology setting.